Isotretinoin® capsules
Isotretinoin capsules is indicated for severe forms of acne (such as nodular or conglobate acne or acne at risk of permanent scarring) resistant to adequate courses of standard therapy with systemic antibacterials and topical therapy.
Due to the nature of Isotretinoin, a suitable physician must supervise the treatment as, with all medicines, there can sometimes be unwanted effects. In particular, is the very high risk of life threatening abnormality to an unborn child if they are exposed to Isotretinoin.
Please read the patient information leaflet carefully before using Isotretinoin capsules.
| Pregnancy Prevention Programme |
|---|
| The UK Medicines and Healthcare products Regulatory Agency (MHRA) have approved and implemented a "Pregnancy Prevention Programme" for Isotretinoin in order to protect female patients and provide information for use by doctors, pharmacists and patients. A selection of Pregnancy Prevention Programme documents can be downloaded as detailed below. Please note that these documents are for information purposes only and it is the responsibility of the user to check with Crawford Healthcare Ltd by telephone or email (details below) that they are using the most current up to date version of the documents. |
A complete pack of the Pregnancy Prevention Programme documents are available on request from Crawford Healthcare Ltd as follows:
Tel: +44 (0) 1565 654920 or email: alison.whittaker@crawfordpharma.com
The Pregnancy Prevention Programme pack will be dispatched to you within 24 hours of your request being received.
| DOWNLOADS AVAILABLE |
|---|
| Acknowledgement for women patients >> |
| Brochure on contraception >> |
| Patient information brochure >> |
| Any medical enquiries relating to Isotretinoin should be directed to our Medical Information team on 0870 192 3283 or email enquiries@medinformation.co.uk |